42 episodes

Hello and welcome to The PEN Perspective Podcast – a space where we share our unique points of view on everything from patient support to customer experience.

One of our core principles at PEN is to prioritise innovation, taking a market leading approach to the way we deliver lasting positive change in the industries where we operate.

Follow us here to keep in touch with our latest insights and hot takes. From our Rise of the Customer series, where Neil Sharp speaks to leaders in a range of industries from banks to football clubs, to Second Opinion, where I break down the latest leading trends in Life Sciences innovation.

Whatever it is, we’re here to understand, explore and inspire. This is The PEN Perspective.

The PEN Perspective Podcast PEN Partnership

    • Business
    • 4.8 • 6 Ratings

Hello and welcome to The PEN Perspective Podcast – a space where we share our unique points of view on everything from patient support to customer experience.

One of our core principles at PEN is to prioritise innovation, taking a market leading approach to the way we deliver lasting positive change in the industries where we operate.

Follow us here to keep in touch with our latest insights and hot takes. From our Rise of the Customer series, where Neil Sharp speaks to leaders in a range of industries from banks to football clubs, to Second Opinion, where I break down the latest leading trends in Life Sciences innovation.

Whatever it is, we’re here to understand, explore and inspire. This is The PEN Perspective.

    More Data, Fewer Patients: Life Sciences Trends in 2023

    More Data, Fewer Patients: Life Sciences Trends in 2023

    From cutting edge innovative pricing and decentralised clinical trials to the fundamentals of transformation principles and strategic partnerships, we have covered some incredibly fascinating topics on this podcast in 2022. But what does 2023 hold for the pharma and life sciences industry?
    In our new episode of the Second Opinion podcast, Shrinivas Anikhindi catches up with Jalilah Gibson and Nick Reynolds, both Associate Partners here at PEN, to explore how the dominant trends of 2022 around cost of care, availability of data and the influence of patients are only strengthening as we enter a new year.
    In this insightful episode, we delve into exactly what you should be preparing for in 2023, both opportunities and pitfalls, including:
    · Finding new ways to support healthcare systems with growing and diversifying patient populations.
    · Increased patient choice and the need to provide greater value.
    · Moving towards hyper segmentation – viewing patients as nuanced individuals and understanding what they truly want.
    · Building data literacy in your organisation at a time of data inundation.
    · Moving to adaptive planning - using the right measurement and the right questions to make the right decisions at the right time
    And much more…
    Don't run the risk of being caught unawares about critical upcoming trends as we enter a fresh new year: listen to this episode to make sure your organisation hits the ground running in 2023.

    • 32 min
    Second Opinion: Intelligent contracting – choosing value over volume

    Second Opinion: Intelligent contracting – choosing value over volume

    The way that the pharmaceutical industry interfaces with healthcare is rapidly changing. Treatment regimens are lasting longer, the burden of care is increasing, and the definition of successful treatment is becoming more nuanced. 

    Given these trends, the way we interface with payers must also evolve. As the quality and complexity of care increase, there is a need to move to models which better enable healthcare systems to get the right treatments to the right people at the right time, and in doing so unchain pharma from the restraints of the traditional volume model. 

    We’ll cover the reasons this is so greatly needed further down, but first consider the following: when value is defined by more than just revenue and cost, what if we could work smarter? Perhaps, in a world of abundantly accessible health data, complex health outcomes, and products that no longer fit in little white bags, we can work in a way that will deliver mutual value by giving healthcare more reliability in value per dollar spent, while giving pharma more agency in their revenue streams.

    • 14 min
    Ep 3. Cloudy Business: Key Outcomes when Moving to the Cloud

    Ep 3. Cloudy Business: Key Outcomes when Moving to the Cloud

    What are the key outcomes you should be looking to achieve when moving to the Cloud?

    In our new episode of the Cloudy Business podcast, Roshni Daswani catches up with Chris Lawrence, Cloud Delivery Architect at Portfolio BI, to discuss both the technical and project management aspects of the Cloud implementation process.

    With a wealth of knowledge under his belt, Chris offers compelling advice on what you should be considering as you move towards the Cloud, including:

    Your cost expectations, and the Cloud offerings you can leverage to save money over time
    The concepts of hot and cold storage; what they are, how they work, and what this means for your data
    Why developing and implementing a data strategy is a critical success factor in your Cloud migration
    Security considerations and the position of the regulator
    How to tackle your legacy applications
    And much more….

    Whether you’re already in the process of migrating to the Cloud or thinking of doing so, this episode will provide you with plenty of information on the ins and outs of implementation.

    • 32 min
    Ep 2. Cloudy Business: Let’s Build Up Your Capability Model

    Ep 2. Cloudy Business: Let’s Build Up Your Capability Model

    Welcome to our second highly anticipated episode of the Cloudy Business Podcast series with Roshni Daswani.

    As more and more businesses consider a move to the Cloud, it’s important to weigh up cost management to maximise your usage. So what key things should you be thinking about when looking for a provider?

    In this fascinating episode, Roshni Daswani is joined by Paul Casey, Chief Technologist at Computacenter, to discuss Cloud cost management in more detail, as well as the controls and governance that need to be implemented.

    With decades of knowledge and experience behind him, Paul is on hand to guide you through Cloud cost models and fin ops models, and the subtle differences between the two.

    Is the I.T. function as we know it a business inhibitor or a business enabler? What capabilities do you need to build in your organisation to adapt to an ever evolving environment?

    Whether you’re currently on the lookout for a Cloud provider, looking to re-assess your strategy or keen to find out how it all works, this is an episode you won’t want to miss.

    • 38 min
    Second Opinion: Wristbands to websites – let’s talk digital health

    Second Opinion: Wristbands to websites – let’s talk digital health

    The more we see of the industry’s approach to digital health, the more we see a need to understand the nuance of the field. To understand where a scalpel is needed versus a sledgehammer. And as always – it starts with the patient.

    • 13 min
    Second Opinion: How Do We Bring Lasting Change to Clinical Trials?

    Second Opinion: How Do We Bring Lasting Change to Clinical Trials?

    Where is the greatest hotbed of innovation within the pharmaceutical industry? At first glance the answer to that question seems obvious – drug discovery and clinical trials are the furnaces of innovation without which the remainder of our industry would surely collapse.

    And yet our approaches to the delivery of clinical trials have struggled to adapt to the needs of modern times, struggling in areas of patient recruitment, retention, and diversity.

    These challenges are of no insignificant threat to our ability to rapidly develop, test, and launch efficacious medicines to the populations that need them. An important question must therefore be asked: What is the key to delivering effective and lasting change in clinical trials?

    In this issue of Second Opinion, we will delve into the challenges faced by those seeking to bring transformation in the clinical trials space, and explore why the importance of change in clinical trial approaches has soared recently, ultimately unlocking the key to delivering effective and lasting change.

    • 11 min

Customer Reviews

4.8 out of 5
6 Ratings

6 Ratings

Top Podcasts In Business

Steven Bartlett
BBC Radio 5 live
Ellie McKay
Global
BBC Radio 4
David Senra